Skip to main content
. 2020 Jul 14;10:11584. doi: 10.1038/s41598-020-68477-2

Figure 4.

Figure 4

PiDose maintains stable drug treatment despite day-to-day changes in bodyweight and water consumption. (a) Mice (n = 10) show gradual and consistent weight gain over the course of two-months of memantine treatment. Data presented as daily mean (red line) ± SEM (red-shaded region). (b) The volume of memantine solution dispensed to a representative mouse is automatically adjusted over the course of 2 months to match changes in bodyweight and ensure consistent dosage. (c) Mice (n = 10) show substantial day-to-day variability in task engagement and total consumption of drops delivered by PiDose. Data presented as daily mean (blue line) ± SEM (blue-shaded region). (d) Daily water consumption during the first week of treatment is positively correlated with daily bodyweight (n = 70), although variability is high.